Meyer A, Meyer N, Schaeffer M, Gottenberg J-E, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology. 2015;54(1):50–63.

CAS  PubMed  Article  Google Scholar 

Lundberg IE, Miller FW, Tjärnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016;280(1):39–51.

CAS  PubMed  PubMed Central  Article  Google Scholar 

McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within the first 5 yr. Rheumatology. 2006;45(10):1255–60.

CAS  PubMed  Article  Google Scholar 

Vincze M, Danko K. Idiopathic inflammatory myopathies. Best Pract Res Clin Rheumatol. 2012;26(1):25.

CAS  PubMed  Article  Google Scholar 

Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, et al. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology (Oxford, England). 2015;54(5):784–91.

CAS  Article  Google Scholar 

Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, et al. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis. Rheumatology. 2016;55(3):470–9.

PubMed  Google Scholar 

Papadopoulou C, McCann LJ. The vasculopathy of juvenile dermatomyositis. Front Pediatr. 2018;6:284.

PubMed  PubMed Central  Article  Google Scholar 

Miller FW, Oddis CV. Vasculitis in the idiopathic inflammatory myopathies. In: In: Inflammatory Diseases of Blood Vessels [Internet]. Hoboken: John Wiley & Sons, Ltd. p. 433–40. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/9781118355244.ch39.

Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2017/08/30 ed. 2018;77(1):30–9.

PubMed  Article  Google Scholar 

Wedderburn LR, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol. 2009;23(5):665–78.

PubMed  PubMed Central  Article  Google Scholar 

Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A. Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools. Front Immunol. 2018;9:2951.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Stenzel W, Goebel H-H, Bader-Meunier B, Gitiaux C. Inflammatory myopathies in childhood. Neuromusc Disorders : NMD. 2021;31(10):1051–61.

PubMed  Article  Google Scholar 

Wedderburn LR, Varsani H, Li CKC, Newton KR, Amato AA, Banwell B, et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Care Res. 2007;57(7):1192–201.

Article  Google Scholar 

Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol. 2004;31(8):1644–9.

PubMed  Google Scholar 

• Papadopoulou C, Hong Y, Krol P, Obaidi M, Pilkington C, Wedderburn L, et al. The vasculopathy of juvenile dermatomyositis: endothelial injury, hypercoagulability, and increased arterial stiffness. Arthritis Rheum. 2021;73:1253–66 CEC, MP, cytokines and chemokines assessed in children with JDM and control populations. CEC and MP levels were elevated in JDM patients compared to healthy controls; CEC levels were increased in patients with active compared to inactive JDM. Galectin-9 was elevated in patients with active disease compared to inactive and this correlated with CEC level.

CAS  Article  Google Scholar 

• Kishi T, Chipman J, Evereklian M, Nghiem K, Stetler-Stevenson M, Rick ME, et al. Endothelial activation markers as disease activity and damage measures in juvenile dermatomyositis. J Rheumatol. 2020;47. https://doi.org/10.3899/jrheum.181275. Various important biomarkers analysed including CEC, vWF, P-selectin and thrombomodulin in children with JDM. These markers were correlated with disease activity. Key findings showed that CEC, vWF were increased in peripheral blood of JDM patients; vWF and P-selectin were not. CEC levels correlated with pulmonary disease activity.

Baka Z, Senolt L, Vencovsky J, Mann H, Simon PS, Kittel Á, et al. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunol Lett. 2010;128(2):124–30.

CAS  PubMed  Article  Google Scholar 

Shirafuji T, Hamaguchi H, Higuchi M, Kanda F. Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients. Muscle Nerve. 2009;39(5):586–90.

CAS  PubMed  Article  Google Scholar 

Oyabu C, Morinobu A, Sugiyama D, Saegusa J, Tanaka S, Morinobu S, et al. Plasma platelet-derived microparticles in patients with connective tissue diseases. J Rheumatol. 2011;38(4):680.

PubMed  Article  Google Scholar 

Notarnicola A, Barsotti S, Näsman L, Tang Q, Holmqvist M, Lundberg I, et al. Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies. Scand J Rheumatol. 2021;50(5):390–7. https://doi.org/10.1080/03009742.2020.1861647.

CAS  Article  PubMed  Google Scholar 

Kumamoto T, Abe T, Ueyama H, Sugihara R, Shigenaga T, Tsuda T. Elevated soluble intercellular adhesion molecules-1 in inflammatory myopathy. Acta Neurol Scand. 1997;95(1):34–7.

CAS  PubMed  Article  Google Scholar 

Figarella-Branger D, Schleinitz N, Boutière-Albanèse B, Camoin L, Bardin N, Guis S, et al. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. J Rheumatol. 2006;33(8):1623.

CAS  PubMed  Google Scholar 

Wienke J, Pachman LM, Morgan GA, Yeo JG, Amoruso MC, Hans V, et al. Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis. Arthritis Rheum. 2020;72(7):1214–26.

CAS  Article  Google Scholar 

Bloom BJ, Miller LC, Blier PR. Soluble adhesion molecules in pediatric rheumatic diseases. J Rheumatol. 2002;29(4):832.

CAS  PubMed  Google Scholar 

Limaye VS, Bonder CS, Sun WY, Lester S, Roberts-Thomson PJ, Blumbergs P. Levels of soluble adhesion molecules and their associations in inflammatory myositis. Int J Rheum Dis. 2013;16(1):99–101.

CAS  PubMed  Article  Google Scholar 

Kubo M, Ihn H, Yamane K, Yazawa N, Kikuchi K, Soma Y, et al. Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis. Br J Dermatol. 2000;143(2):392–8.

CAS  PubMed  Article  Google Scholar 

Kim E, Cook-Mills J, Morgan G, Sredni ST, Pachman LM. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126. Arthritis Rheum. 2012;64(11):3809–17.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Komiya T, Negoro N, Kondo K, Miura K, Hirota Y, Yoshikawa J. Clinical significance of von Willebrand factor in patients with adult dermatomyositis. Clin Rheumatol. 2005;24(4):352–7.

PubMed  Article  Google Scholar 

Funauchi M, Shimadsu H, Tamaki C, Yamagata T, Nozaki Y, Sugiyama M, et al. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol. 2006;33(5):903.

PubMed  Google Scholar 

Scott JP, Arroyave C. Activation of complement and coagulation in juvenile dermatomyositis. Arthritis Rheum. 1987;30(5):572–6.

CAS  PubMed  Article  Google Scholar 

Chai K-X, Chen Y-Q, Fan P-L, Yang J, Yuan X. STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis. Medicine (Baltimore). 2018;97(34):e11775.

Article  CAS  Google Scholar 

Silva T, Silva M, Shinjo S. Relevance of serum angiogenic cytokines in adult patients with dermatomyositis. Adv Rheumatol. 2018;58:17.

PubMed  Article  Google Scholar 

Szodoray P, Alex P, Knowlton N, Centola M, Dozmorov I, Csipo I, et al. Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand. Rheumatology (Oxford). 2010/06/29 ed. 2010;49(10)):1867–77.

CAS  Article  Google Scholar 

Tawalbeh SM, Marin W, Morgan GA, Dang UJ, Hathout Y, Pachman LM. Serum protein biomarkers for juvenile dermatomyositis: a pilot study. BMC Rheumatol. 2020;4:52.

PubMed  PubMed Central  Article  Google Scholar 

Liao AP, Salajegheh M, Nazareno R, Kagan JC, Jubin RG, Greenberg SA. Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis. 2011;70(5):831.

CAS  PubMed  Article  Google Scholar 

Chen M, Quan C, Diao L, Xue F, Xue K, Wang B, et al. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Br J Dermatol. 2018;179(6):1334–41.

CAS  PubMed  Article  Google Scholar 

Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, et al. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology. 2014;53(12):2196–203.

CAS  PubMed  Article  Google Scholar 

Melki I, Devilliers H, Gitiaux C, Bondet V, Belot A, Bodemer C, et al. Circulating Interferon-α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity: comment on the article by Mathian et al. Arthritis Rrheumatol (Hoboken, NJ). 2020;72(1):195–7.

Google Scholar 

Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med 2017/04/18 ed. 2017;214(5):1547–55.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Niewold TB, Kariuki SN, Morgan GA, Shrestha S, Pachman LM. Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum. 2009;60(6):1815–24.

CAS  PubMed  PubMed Central  Article